Remove Packaging Remove Pharma Companies Remove Regulation Remove Vaccine
article thumbnail

Thursday pharma headlines

World of DTC Marketing

Amgen CEO Bob Bradway racked up a 2018 pay package of $18.6 million while the company’s pipe line falters. regulators knew about reports of suicidal behavior in men taking the anti-baldness treatment Propecia when they decided not to warn consumers of those potential risks in a 2011 update of the popular drug’s label.

article thumbnail

Guido Rasi steps down, handing the running of EMA to Emer Cooke

pharmaphorum

EMA executive director Guido Rasi has ended his second term at the helm of the EU medicines regulator, with Emer Cooke taking the wheel and becoming the first women in the role. Cooke is returning to the EMA after a four-year period as head of medicines regulation at the World Health Organization (WHO). Emer Cooke.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Can technology help diversify clinical trials?

pharmaphorum

Once stakeholders are confident that technologies are adequately validated, selection based on scientific and ethical considerations can be presented to regulators in accordance with applicable legal and regulatory frameworks. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

Only a limited number of international pharma companies, however, operate manufacturing sites in the country. Brazilian pharma production sites are involved in Covid-19 vaccine and therapy manufacture. Large Brazilian pharma companies already play a major role in distributing Covid-19 vaccines to all of Latin America.

article thumbnail

European Commission vs Big Pharma, or profit vs access?  

Drug Discovery World

The commission is looking to put more pressure on pharma companies to report such shortages, and to offer a drug’s marketing authorisation to another company before withdrawing it from the market. This looks like it may change shape in the future for the region, if the proposal put forward by the commission is adopted.

article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

US President Joe Biden has gained approval from Congress for a new package of aid worth $40bn, and the US government announced last month that it plans to provide an additional $1bn in security assistance to Ukraine. million vaccine doses upon EMA authorisation. Roszdravnadzor was founded by Vladimir Putin in 2004.

article thumbnail

Why are clinical trials struggling with diversity?

pharmaphorum

While many pharma companies are actively working on initiatives to improve diversity in clinical trials, we still have a long way to go. The race to produce a vaccine which could protect the world against COVID-19 brought the topic of diversity in clinical trials, or lack of it, into sharp focus.